← Leaderboards
Subramaniam Sriram
Vanderbilt University
$1,188,323
Attributed
$1,188,323
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $179.6K · FY2005–09$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,188,323 · 4
By mechanism
R21$620,731 · 2
R01$567,000 · 1
M01$592 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Jon H Kaas$16,063,275
- Hui-Xin Qi$2,029,583
- Harold L Moses$33,288,478
- Li Min Chen$12,202,288
- Robert L Barry$4,121,374
Others in their field
Top investigators on “Multiple Sclerosis”
- David A. Hafler · Brigham And Women'S Hospital$33,720,341
- Vijay K Kuchroo · Brigham And Women'S Hospital$32,935,587
- Stephen L Hauser · University Of California San Francisco$32,469,388
- Katerina Akassoglou · University Of California San Diego$24,525,425
- Abdolmohamad Rostami · Thomas Jefferson University$23,969,638
- Stephen D Miller · Northwestern University$23,969,272
Research focus
Multiple SclerosisClinical ResearchHuman SubjectLymphocyteHuman Therapy EvaluationCell AdhesionBlood Brain BarrierAntiinflammatory AgentsImmunoregulationVascular EndotheliumMyelinInflammationNervous System Disorder ChemotherapyOligodendrogliaClinical Trial Phase IBacterial ProteinsBacterial PneumoniaMembrane ProteinsBacterial AntigensBacteria Infection MechanismAntigen Antibody ReactionCerebrospinal FluidCentral Nervous System DisordersElectron Microscopy
Grant awards (12)
Neuroimaging and neuroprotection of primary oligodendrogliopathy$147,979
R21 · FY2009 · NS · contact PI
Neuroimaging and neuroprotection of primary oligodendrogliopathy$179,631
R21 · FY2008 · NS · contact PI
Novel oral therapeutics for multiple sclerosis$144,861
R21 · FY2006 · NS · contact PI
Novel oral therapeutics for multiple sclerosis$148,260
R21 · FY2005 · NS
ANALYSIS OF ASSOCIATION BETWEEN C. PNEUMONIAE AND MS$189,000
R01 · FY2002 · NS
ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS$0
M01 · FY2002 · RR
ANALYSIS OF ASSOCIATION BETWEEN C. PNEUMONIAE AND MS$189,000
R01 · FY2001 · NS
ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS$0
M01 · FY2001 · RR
ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS$0
M01 · FY2001 · RR
ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS$0
M01 · FY2001 · RR
ANALYSIS OF ASSOCIATION BETWEEN C. PNEUMONIAE AND MS$189,000
R01 · FY2000 · NS
ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS$592
M01 · FY2000 · RR